Longeveron (LGVN) Assets (2021 - 2026)
Longeveron (LGVN) posted quarterly Assets of $21.2 million for Q1 2026, up 1.74% year-over-year from $20.8 million in Q1 2025, and up 106.7% quarter-over-quarter from $10.3 million in Q4 2025.
Longeveron (LGVN) Assets (2021 - 2026) Analysis & Trends
Longeveron's Assets history runs 6 years deep, the most recent figure standing at $21.2 million for Q1 2026.
- In Q1 2026, Assets rose 1.74% year-over-year to $21.2 million; the TTM figure through Mar 2026 stood at $21.2 million (up 1.74% YoY), while the FY2025 annual figure was $10.3 million, down 59.85% from the prior year.
- Assets for Q1 2026 stood at $21.2 million, up from $10.3 million in the prior quarter.
- The five-year high for Assets was $29.9 million in Q3 2024, with the low at $9.7 million in Q1 2024.
- The 5-year median for Assets is $18.2 million (2023), against an average of $18.5 million.
- The sharpest annual moves came in 2024 and 2025: Assets surged 157.28% in 2024, then plunged 59.85% in 2025.
- Longeveron's Assets stood at $27.4 million in 2022, then slumped by 55.94% to $12.1 million in 2023, then surged by 111.61% to $25.6 million in 2024, then slumped by 59.85% to $10.3 million in 2025, then soared by 106.7% to $21.2 million in 2026.
- Business Quant data shows LGVN's Assets at $21.2 million in Q1 2026, $10.3 million in Q4 2025, and $15.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 | 15.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.49 Mn |
| Mar 31, 2026 | 21.21 Mn |
| Dec 31, 2025 | 10.26 Mn |
| Sep 30, 2025 | 15.56 Mn |
| Jun 30, 2025 | 16.75 Mn |
| Mar 31, 2025 | 20.85 Mn |
| Dec 31, 2024 | 25.56 Mn |
| Sep 30, 2024 | 29.91 Mn |
| Jun 30, 2024 | 19.39 Mn |
| Mar 31, 2024 | 9.70 Mn |
| Dec 31, 2023 | 12.08 Mn |
| Sep 30, 2023 | 11.63 Mn |
| Jun 30, 2023 | 17.09 Mn |
| Mar 31, 2023 | 21.81 Mn |
| Dec 31, 2022 | 27.41 Mn |
| Dec 31, 2021 | 42.77 Mn |